Michael G.  Erickson net worth and biography

Michael Erickson Biography and Net Worth

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine of IDEXX Laboratories

Dr. Erickson has been an Executive Vice President of IDEXX and General Manager of IDEXX’s Global Point of Care Diagnostics and Telemedicine businesses since January 2024. He previously served as a Senior Vice President from January 2020 to December 2023, a Corporate Vice President from January 2018 to January 2020, and a Vice President from 2014 to 2017. Dr. Erickson joined IDEXX as Senior Director and General Manager in 2011 and took on increasing leadership responsibilities, including as General Manager of Veterinary Software and Services from 2014 to 2018, General Manager of Corporate and Strategic Accounts from October 2018 through December 2022, and General Manager of Global Point of Care Diagnostics from January 2023 to December 2023. In addition, Dr. Erickson led our Corporate Strategy and Advanced Analytics organization in 2022. Before joining IDEXX, Dr. Erickson was an Associate Principal in the Global Pharmaceutical Practice at McKinsey & Company where he served leading pharmaceutical, biotechnology and health service companies across areas in commercial, business development and health technology innovation. He earned his PhD in Biomedical Engineering at the Johns Hopkins School of Medicine and his Bachelor of Science degree in Electrical Engineering from Purdue University. 

What is Michael G. Erickson's net worth?

The estimated net worth of Michael G. Erickson is at least $8.10 million as of August 12th, 2025. Dr. Erickson owns 11,287 shares of IDEXX Laboratories stock worth more than $8,098,084 as of December 4th. This net worth estimate does not reflect any other investments that Dr. Erickson may own. Learn More about Michael G. Erickson's net worth.

How do I contact Michael G. Erickson?

The corporate mailing address for Dr. Erickson and other IDEXX Laboratories executives is ONE IDEXX DRIVE, WESTBROOK ME, 04092. IDEXX Laboratories can also be reached via phone at (207) 556-0300 and via email at [email protected]. Learn More on Michael G. Erickson's contact information.

Has Michael G. Erickson been buying or selling shares of IDEXX Laboratories?

Michael G. Erickson has not been actively trading shares of IDEXX Laboratories in the last ninety days. Most recently, Michael G. Erickson sold 406 shares of the business's stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $649.96, for a transaction totalling $263,883.76. Following the completion of the sale, the executive vice president now directly owns 11,287 shares of the company's stock, valued at $7,336,098.52. Learn More on Michael G. Erickson's trading history.

Who are IDEXX Laboratories' active insiders?

IDEXX Laboratories' insider roster includes Jonathan Ayers (Director), Bruce Claflin (Director), Michael Erickson (Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine), George Fennell (SVP), Rebecca Henderson (Director), Nimrata Hunt (EVP), Daniel Junius (Director), Michael Lane (EVP), Jonathan Mazelsky (CEO), Brian Mckeon (CFO), James Polewaczyk (EVP), M. Szostak (Director), Kathy Turner (SVP), Kathy Turner (SVP), Giovani Twigge (SVP), Sharon Underberg (EVP), and Sophie Vandebroek (Director). Learn More on IDEXX Laboratories' active insiders.

Are insiders buying or selling shares of IDEXX Laboratories?

During the last year, insiders at the sold shares 12 times. They sold a total of 78,774 shares worth more than $48,122,012.42. The most recent insider tranaction occured on November, 7th when EVP Nimrata Hunt sold 9,425 shares worth more than $6,628,979.50. Insiders at IDEXX Laboratories own 1.0% of the company. Learn More about insider trades at IDEXX Laboratories.

Information on this page was last updated on 11/7/2025.

Michael G. Erickson Insider Trading History at IDEXX Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/12/2025Sell406$649.96$263,883.7611,287View SEC Filing Icon  
See Full Table

Michael G. Erickson Buying and Selling Activity at IDEXX Laboratories

This chart shows Michael G Erickson's buying and selling at IDEXX Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IDEXX Laboratories Company Overview

IDEXX Laboratories logo
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Read More

Today's Range

Now: $717.47
Low: $714.17
High: $732.03

50 Day Range

MA: $674.30
Low: $616.15
High: $766.68

2 Week Range

Now: $717.47
Low: $356.14
High: $769.98

Volume

526,184 shs

Average Volume

603,125 shs

Market Capitalization

$57.29 billion

P/E Ratio

56.90

Dividend Yield

N/A

Beta

1.67